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1. Introduction 
 
Information Science is a field that deals with the analysis, collection, classification, 
manipulation, storage, retrieval, movement, and dissemination of information in various 
different fields and organizations. There are various areas of information science such as 
Information Access, Information Architecture, Information Management, Information 
Retrieval, etc. This paper is about Information Management and how information is 
organized and structured in databases. 
One important field for the application of information science and information 
management is medical informatics. There are various types of information and ways to 
organize such information in medical field is gaining prominence in the current world of 
technology. Organized and structured data enable medical information to be easily 
accessible and understandable by end users. There are many medical drugs databases 
available currently for adults but there is no database for pediatric drugs that can benefit 
end users who are looking for information specific to drugs for children. So the Division 
of Pediatric Hematology Oncology in UNC, Chapel Hill wants to have a repository to store 
and organize information about pediatric drugs in order to provide this information in a 
structured and easily accessible format that will benefit end users. Also this database will 
be used to provide information to end-users especially consumers about drug repurposing 
i.e. using the same pediatric drug for more than one purpose. The main goal of this project 
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is to research existing medical repositories on how they organize, structure and 
curate medical data and design and create a storage system for pediatric drugs. This 
database provides access to information about pediatric drugs to end-users consumers, 
scientists, pharmaceutical companies and physicians and also provide information about 
the repurposing of pediatric drugs. As a part of this project I would like to analyze existing 
medical databases and understand how they are structured, organized and curated in order 
to design an effective database system for pediatric drugs.  
2. Literature Review 
 
The data used for this drug repository is from the JHCCL database and is specific 
to a particular domain. There is a lot of literature about organizing and curating medical 
data for medical databases and the literature reviewed, as part of this proposal will provide 
a brief overview about the same. The available literature will provide the basis for 
analyzing existing medical databases and how data is curated in these databases. The 
literature review is organized on the topics below: 
 
2.1. Introduction to Databases 
  
There are many definitions for database and database management systems. Some 
of the definitions I came across are: database is a collection of organized data (Wikipedia), 
collection of related data (Navathe, Shamkant B., and Ramez Elmasri.). Overall a database 
is a collection of data that is organized in such a way that makes it easier to search and 
retrieve data effectively and efficiently. A database can generally be of any size and 
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complexity and the size and complexity depend on the data that is stored in a database. 
Databases have become an integral part of information science and information 
management.  
 In the book Fundamentals of Database (Navathe, Shamkant B., and Ramez 
Elmasri.), Database Management System is defined as “A database management system 
(DBMS) is a collection of programs that enables users to create and maintain a database. “ 
 There are many different types of DBMS and different basis of classifying 
them. For the basis of this paper we will discuss about Relational, Object Oriented and 
XML databases. Relational Databases are based a collection of tables (Navathe, Shamkant 
B., and Ramez Elmasri.) and the unit of information in relational database is a two 
dimensional array of rows and columns which are simple and easy to understand (Dr. 
Hazem El-Oraby). Object Oriented Databases store data as objects (Navathe, Shamkant B., 
and Ramez Elmasri.) and they are completely different from a relational database. XML 
databases is a system that stores information in XML (Xtensible Markup Language) format 
and it is built on the notion of tags. (Dr. Hazem El-Oraby). 
2.2. Introduction to Biomedical Databases 
  
As Dr. Hazem El-Oraby says in his lecture  
"[Medical Informatics] is the science of organizing information to make it useful, 
to make it retrievable, so people can use it to solve health problems and understand health 
and disease better. It is the technology for implementing that science, such as databases, 
communication networks, and other forms of digital tools.”   
There is a lot of medical information available currently and it is essential and 
important to organize such information in order to benefit end users of such systems. In 
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today’s world of technological advancements a lot of importance is given to biomedical 
databases. Many physicians, pharmaceutical companies, patients, etc. are using clinical 
repositories for easier access to medical information. As mentioned in the book Computer 
Medical Databases, medical databases evolved from the 1950s using a centralized 
computer to using later advancements such as relational databases. Database structure is 
very important for medical database and this book talks about several database structural 
designs such as Hierarchical tree-structured databases, Relational Databases, Object 
Oriented Databases and Entity Attribute Value Databases. As mentioned in the book, 
medical databases are broadly classified based on their objectives that are either to support 
clinical patient care, to support medical research or to support administrative functions or 
public health objectives.  
 The need for medical databases and medical information systems has 
increased exponentially in the past few years because they provide the “right information 
and knowledge at the right time at the right place to the right people in the right form. 
(Source: Heath Information Systems)” 
 
2.3. Database Structure and Organization 
   
        There are multiple types of database that are used for medical databases and 
some of them are Object Oriented (Peri, Suraj, et al), XML (Shiffman, Richard N., et al.)  
, Ultrastructure (Jeff Long et. Al), Relational.  As mentioned in GlycoSuiteDB (Cooper, 
Catherine A., et al.) relational databases ensure data consistency and also allow flexible 
querying of the database. In his lecture Dr. Hazem El-Oraby discusses the advantages and 
disadvantages of using the different databases for medical information. One of the main 
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advantages of using a relational database is it is easy to modify the structure of a relational 
database and adding new attributes to it will not break the system. A disadvantage of using 
a relational database is that it is I/O intensive. The advantages of an object oriented database 
is that it has a lot of features such as its ability to store multiple data types, includes the 
concept of encapsulation. The disadvantages of object oriented database is that it does not 
have a uniform language such as SQL in relational database. The advantages of XML 
database are it’s a powerful model and it is flexible and can represent a wide range of data. 
The disadvantage is that the tools used by this database is not as efficient and mature as a 
relational database.  
      Some of the available biomedical databases and the database structure they use 
are mentioned here.  Human Metabolome Database (Wishart, David S., et al.), BioModels 
Database (Li, Chen, et al) and Pfam protein families database (Bateman, Alex, et al) use 
MYSQL database for storing information in a relational model while Mouse Genome 
Database (Bult, Carol J., et al) uses a Sybase relational database management system. The 
ExoCarta: database of exosomal proteins, RNA and lipids (Mathivanan, Suresh, et al.) also 
uses a MYSQL relational database system to store data.  The Human Protein Reference 
Database (HPRD) (Peri, Suraj, et al) uses an object oriented database because of the 
complexity of the data. The HPRD database uses Zope which is an open source web 
application server and Python which is an open source programming language.  The 
Guidelines Elements Model (GEM) database (Shiffman, Richard N., et al) serves as a 
document model and so uses XML database since this offers a powerful technology for 
representing electronic documents. The MITOMAP database (Brandon, Marty C., et al) 
uses an object-relational database structure which is managed in a PostgreSQL database, 
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this database uses an object-relational database because of the flexibility of the object 
oriented model and better data modeling capabilities. The protein NMR database (Seavey, 
Beverly R., et al) uses an Oracle relational database system. The Pathogen Host 
Interactions (PHI) (Winnenburg, Rainer, et al.) database is a relational database which uses 
a PostgreSQL system. The Cell Line Data Base (Romano, Paolo, et al.) uses relational 
database system, it was initially built using an Oracle database but recently it has been 
changed to a MYSQL database. Some of the reasons for many of the databases to use a 
relational model is because it’s simpler, easy to use and understand and effective, most of 
these databases have structured content and they use an interface for search and retrieval 
of data and using a relational database makes it more compatible, also relational databases 
have a uniform SQL (standard query language) that can be used across multiple platforms.  
Another important discussion on database structure is the centralized vs federated 
data repositories. In the article “Centralized vs. Federated: State Approaches to P-20W 
Data Systems” the author defines centralized data system as “in a centralized data system, 
all participating source systems copy their data to a single, centrally-located data repository 
where they are organized, integrated, and stored using a common data standard.” 
And federated data system as  “In a federated data system, individual source 
systems maintain control over their own data, but agree to share some or all of this 
information to other participating systems upon request.“ 
 In simpler words a federated database is one that makes multiple databases 
look a single database  
(Source:http://criticaltechnology.blogspot.com/2012/10/federated-databases-with-
digital-badges.html) 
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          The BioModels Database (Li, Chen, et al), Human Metabolome 
Database (Wishart, David S., et al.) is a centralized database. The SPINE 2(Goh, Chern‐
Sing, et al) is a federated database. 
        Even though there are different database structures used in biomedical 
databases, one common and simpler structure is a relational database structure for the 
pediatric drug database.  
2.4. Search and Retrieval  
 
        Data accuracy is very important for effective search and retrieval of medical 
information. The entire purpose of data curation and management is to improve search and 
retrieval of information that will benefit end users. Manual annotation enables effective 
search and retrieval in medical databases. Metadata is another important point for effective 
information search and retrieval. In the BioModels database (Li, Chen, et al) “The searches 
are performed sequentially as follows: (1) querying metadata, publications and annotations, 
(2) searching the model bodies, and (3) searching supplementary information from external 
resource databases” 
In the HPRD database (Peri, Suraj, et al) search can be performed on multiple 
annotation fields. This database also uses manual annotation of fields. The Pathogen Host 
Interactions (PHI) (Winnenburg, Rainer, et al.) database uses a web interface that can be 
accessed through any web browser for search and retrieval. The PHI database uses PHP as 
the server side scripting language. This web interface provides two different search options, 
full text search is performed on the whole database whereas specific fields are searched 
using the Quick search option. An advanced search option is also used which help 
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formulate SQL queries based on the search input. The ExoCarta: database of exosomal 
proteins, RNA and lipids (Mathivanan, Suresh, et al.) is built with ZOPE, an open source 
Python-based web application server with dynamic HTML templates, scripts, a search 
engine and connections for a relational database. The Cell Line Data Base (CLDB) 
(Romano, Paolo, et al.) use HyperCLDB for search and retrieval. HyperCLDB is a 
hypertext version of CLDB, this is a static version of CLDB. 
        There are some large databases that will have issues with fast retrieval 
of data. In order to overcome this problem some databases such as GenBank() that use a 
local copy of the data in order to reduce retrieval time.  
2.5. Data Curation 
 
         The general trend for data curation in medical databases is manual. All the 
literature reviewed here support manual annotation and curation. Experts in the field 
perform curation since not everyone will be able to determine and analyze medical data. In 
the BioModels database (Li, Chen, et al) they use a BioModels Database Curator Team in 
order to perform curation. This is a  
“Freely accessible online resource for storing, viewing, retrieving, and analyzing 
published, peer-reviewed quantitative models of biochemical and cellular systems. The 
structure and behavior of each simulation model distributed by BioModels Database are 
thoroughly checked; in addition, model elements are annotated with terms from controlled 
vocabularies as well as linked to relevant data resources.”    
              The Biomodels Database Curation Team consists of actors who were 
involved in converting the information from citation articles to the database that includes 
authors of the citation articles and person who encodes the information to be stored in the 
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database. This database uses a model exchange format called Systems Biology Markup 
Language (SBML), which is the often-used model for information exchange in this field. 
SBML is then used to perform data consistency checks on the models that are stored in the 
database. Similarly annotation is also carried out manually. The DrugBank (Wishart, David 
S., et al) database has a curation team that consists of PhD level biochemists, pharmacists 
and a physician and each entry into the database is reviewed by two members of the 
curation team. In Yeast Protein Database (Hodges, Peter E., William E. Payne, and James 
I. Garrels), MetaCyc (Caspi, Ron, et al) and Human Metabolome (Wishart, David S., et 
al.) databases curation is performed manually and also all three databases are curated by 
PhD level curators who are experts in their respective fields. The Pathway Interaction 
database (PID) (Schaefer, Carl F., et al.) also uses manual curation where experts in the 
field review each entry into the database. ChemSpider (Pence, Harry E., and Antony 
Williams) is a popular online chemical information resource where curation is performed 
by registered users of the resource whereas Mouse Genome Database (Bult, Carol J., et al) 
uses a curator team for curation. Curation in the BioGrid Database (Stark, Chris, et al.) is 
performed by PhD level curators using an Interaction Management System. The Pathogen 
Host Interactions (PHI) (Winnenburg, Rainer, et al.) database is curated by a domain expert 
and it was supported by strong experimental evidence. The EMBL nucleotide sequence 
database (Stoesser, Guenter, et al) is curated by a team of biological curators who verify 
each entry into the database to ensure all the required information is entered and the data 
follows the rules of the database. Data curation in the GeneDB: a resource for prokaryotic 
and eukaryotic organisms (Hertz‐Fowler, Christiane, et al.) is carried out by a team of 
experienced biologists, every entry into the database is verified and the entries in the 
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database are updated based on the new entry. The data curation of this database involves 
several aspects and all aim to facilitate data querying and retrieval. The ExoCarta: database 
of exosomal proteins, RNA and lipids (Mathivanan, Suresh, et al.) and miR2Disease: 
database for microRNA deregulation in human disease (Jiang, Qinghua, et al.) are also 
manually curated databases system. The Cell Line Data Base (Romano, Paolo, et al.) uses 
a curator team for manual curation, data curators have access to modify database contents 
for which they are responsible.   
   The reason behind using experts for curation is consistency, 
completeness and accuracy of the data being presented to end-users. End users of medical 
databases are not necessarily experts and will not be able to identify inconsistent and 
inaccurate data so the information that is being presented should be consistent and accurate. 
The literature reviewed here provides a brief overview about the important methods for 
this proposal. Possible solutions for the evaluation are derived from this and discussed in 
detail in the methods and expected results sections below.  
          A common way to store this data is in a relational database using open source 
software such as MYSQL, PostgreSQL. The advantages of using a relational database for 
this purpose are: data consistency, ease of querying, relating to another table is also 
possible with relational database. The important reasons for choosing a relational database 
to represent this data is the schema will not change and will remain constant and the volume 
of data in this database will not increase exponentially over time so using a relational 
database will ensure the quality and accuracy of the data. 
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3. Project Scope 
 
I became involved with this project as an independent study during spring 2013 
around February 2013. This project started with a brief meeting to discuss the scope of the 
project with my advisor and members of the Division of Pediatric Hematology Oncology 
in UNC, Chapel Hill. This project began because clinical researchers at UNC hospital 
wanted to have a way to store, curate and share information about drugs used for children.  
They realized they didn’t have the knowledge set necessary to accomplish this so they 
involved people with the needed expertise (including chemists, pharmacists and 
information scientists). Our aim as a team was to analyze and understand the user groups 
their needs and to design a data repository to store information about pediatric drugs based 
on the analysis and needs of the user groups. My goal as part of this team was to analyze 
how existing medical databases store and curate data and design a database for pediatric 
drugs based on this analysis.  
This was a pilot project and the team did not have enough funding for the project, 
so the scope of my project was limited to research and designing and creating the database 
and also providing a solution for data curation based on my research. I started work on the 
database during the middle of the spring semester and after having multiple discussions 
with the team in the Division of Pediatric Hematology Oncology in UNC, Chapel Hill came 
up with the final design and created the database and loaded them during summer of 2014. 
The specific objectives for this paper are: 
 Apply database and web skills to a data publication project in the UNC medical 
school. 
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 Build a repository that organizes and provides structure to information about 
pediatric drugs.  
 Understand existing medical repositories and data management and curation 
techniques used. 
4. Methods 
 
The objectives for this project as mentioned above are: 
 Apply database and web skills to a data publication project in the UNC medical 
school. 
As an information science student specializing in information organization I took 
the courses Systems Analysis, Information Organization, Intermediate Databases, 
Web Databases and Advanced Databases. This project provided me an opportunity 
to apply the knowledge I gained from these courses.  
 Build a repository that organizes and provides structure to information about 
pediatric drugs.  
 Understand existing medical repositories and data management and curation 
techniques used. 
In order to meet the above three goals the following steps were implemented.  
4.1. Systems Requirements 
  
The requirements for this database system was provided to me by the Division of Pediatric 
Hematology Oncology in UNC, Chapel Hill. The Oncology team wanted a database system 
that can store pediatric drugs in a database system to enable effective and efficient retrieval 
of data. The team involved in this project consisted of doctors, chemists, pharmacists and 
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information scientists. The Oncology team provided a brief overview about the project and 
the needs and requirements of the users of the database system. The main reason for 
creating this database is that there is no existing database for pediatric drugs. The Oncology 
team thought that having a specialized database for pediatric drugs will benefit parents of 
children with illnesses and also physicians, pharmacists and scientists looking for 
information specific to pediatric drugs. Currently they would have to go through large 
databases containing information about all drugs available. The details about the users of 
the system and their needs/requirements are provided below: 
The main reason this database will be useful for the below user group is that it provides 
information pertaining specifically to pediatric drugs. The users for this database were 
grouped as below: 
 Scientists: Scientists researching about pediatric drugs will find this database useful 
especially for information regarding drug repurposing. (I.e. using the same drug for 
more than one use). This database will also provide the chemical structure for 
pediatric drugs for scientists for research.  
 Clinicians: This database should ensure that clinicians or doctors will find this 
database useful especially for information regarding pediatric drugs. 
 Consumers: Consumers of this database will specifically be parents of children with 
a range of illnesses who will use this database in order to identify the different uses 
of various pediatric drugs.  
 Pharmaceuticals: Pharmaceuticals will also find this database useful especially for 
information regarding drug repurposing. (i.e. using the same drug for more than 
one use) and to retrieve information about the chemical structure of pediatric drugs. 
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After consultation with all the project participants, we developed the following initial list 
of user queries for this data (by user group): 
Scientists: 
1.     What are the original/repurposed uses for specific drugs? 
2.     Do other drugs in category/with original indications/with similar chemical 
structure/similar MOA have potential for similar repurposing? 
3.     What structures similar to this one exist outside the database (requires download of 
structure file)? 
Clinicians: 
1.     What are the original/repurposed uses for specific drugs? 
2.     Based on repurposing data, are any of the drugs of interest for phase II clinical trials? 
3.     Which drugs are FDA approved in pediatrics and for what indications?  
Consumers: 
1.     What drugs are FDA approved in children? 
2.     Have consumers used a particular drug for other than approved or conventional 
indications? What was their experience (and evidence for comments)? 
3.     What is the MOA and what drug have similar MOA for comparison? 
Pharmaceuticals: 
1.     What are the original/repurposed uses for specific drugs? 
2.     Do other drugs in category/with original indications/with similar chemical 
structure/similar MOA have potential for similar repurposing? 
3.     Patent status 
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4.     Do other drugs in category/with original indications/with similar chemical 
structure/similar MOA have potential for similar repurposing? 
5.     What structures similar to this one exist outside the database (requires download of 
structure file)? 
I had multiple discussions and meetings with the Oncology team along with my advisor to 
discuss about the requirements of the system. Since the team consisted of people with 
limited knowledge about databases, my main aim was to understand their requirements in 
plain English and convert it to technical requirements. I analyzed the above queries and 
came up with a list of columns for the database and then translated the above queries into 
SQL queries. Another important point I had to consider was the cost since this was a new 
project and the team did not have funding for the project. So I had to ensure that I either 
use less expensive database software system or open source ones which are available for 
free.  
4.2. Data Collection 
  
For this project the data was already collected and was provided by the Division of 
Pediatric Hematology Oncology in UNC, Chapel Hill in an excel spreadsheet. The first 
part of this project was to understand the data provided and analyze the provided data in 
order to convert this plain text data into a relational database. The Oncology team collected 
the data from the existing John Hopkins Drug Database and combined with this their 
research based on pediatric usage of the drugs. The team also identified if the drugs were 
FDA approved and the uses/indications of the drugs along with the age ranges for using 
the drugs. From the JHCCL database the team identified approximately 1250 drugs as 
pediatric drugs. 
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4.3. Initial Database Design 
  
 The next part of the project was to gather information about the users and the type 
of questions they would ask so the database can be designed to provide answers for the 
user queries. The user queries were gathered from the Division of Pediatric Hematology 
Oncology in UNC, Chapel Hill in plain text and converted into technical queries.  
The database was designed based on these queries. Initially a single database was created 
as a draft and data was loaded into this database. Further discussions with members of 
Division of Pediatric Hematology Oncology in UNC, Chapel Hill lead to the creation of 
three databases. The structure and organization of these databases are discussed in detail 
in the next section. 
4.4. Data Curation 
 
  The curation of data was already done by the UNC Oncology Department 
and they provided us with the excel sheet with the data that requires to be loaded into this 
database. From the literature review it was identified that majority of medical databases 
use manual curation. This is mainly because medical data is highly sensitive and requires 
experts in the medical field for curation.  Since this is a new database the number of people 
involved in the annotation and curation is considerably less. The following steps were 
performed by the Oncology Department in UNC and the data was provided to me.  
 The first step in data annotation was identifying a unique identifier that will enable 
unique identification of each drug in the database. This database consists of ~1200 
pediatrics drugs so a four-digit identifier named CPC ID was used. Also this 
database is not expected to increase in volume exponentially so the ID will not 
exceed four digits.  
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 The next step is identifying the metadata based on end-users needs and 
requirements. Analysis and understanding of the user population led to the 
documentation of questions/queries of the particular user population i.e. a set of 
queries were constructed for consumers, pharmaceutical companies, scientists and 
physicians.  The metadata required for each drug was then identified from the 
above.  
I analyzed the data from above and the databases were created, the detailed steps about 
creating the database is discussed below. 
                Currently there is no specific team for curation but a curation team will be formed 
eventually to maintain this database. This curation team will manually check each drug and 
its corresponding metadata before this information goes into the database.   
4.5. Database Structure and Organization  
 
 A snapshot of the excel spreadsheet with which this project was started is provided 
below: 
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The above excel was used as an initial design and the first step was to create a 
database with the same fields as the above excel which was as below: 
Field Type   Description Null Key Default 
      
CPC_ID char(7) Unique ID NO PRI NULL 
JHCCL_ID int(11) 
ID from the John 
Hopkins Database YES  NULL 
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generic_name varchar(30) 
Chemical name of 
the drug YES  NULL 
brand_name varchar(30)  YES  NULL 
chem_name varchar(100) 
Chemical 
Composition of the 
drug YES  NULL 
SMILES varchar(100) 
Chemical structure 
of the drug YES  NULL 
category varchar(20) 
Category the drug 
belongs to YES  NULL 
FDA_adults varchar(5) 
FDA approved for 
adults YES  NULL 
FDA_PEDS varchar(10) 
FDA approved for 
children YES  NULL 
indication varchar(100) 
General use of the 
drug YES  NULL 
indication_preclinical varchar(100)  YES  NULL 
indication_pateint varchar(30)  YES  NULL 
MOA varchar(100) 
Mechanism of 
action YES  NULL 
company varchar(40) 
Company that 
produced the drug YES  NULL 
link_to_website varchar(30) 
Link to other 
websites.  YES  NULL 
  
Definitions of all the table elements: 
CPC_ID:  Childrens Pharmacy Collaborative ID. This is a unique ID to identify each drug. 
The CPC_ID was assigned by the Oncology team and currently it ranges from CPC_0001 
to CPC_1242. It can hold up to CPC_9999 values. 
JHCCL_ID: This is ID taken from the John Hopkins Database. It is used mainly as a 
reference to the master John Hopkins Database. This is an integer and has values from 0 to 
999999. In our database there is no specific range since it is taken from the JHCCL 
Database. 
generic_name: This is the chemical name of the drug and it will indicate the main 
ingredient of the drug. The generic ingredient can have many different brand names. 
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brand_name: This is the commonly used name of the drug and it is given by the company 
producing the drug. For example: Tylenol is the brand name of the drug and acetaminophen 
is the generic name.  
chem_name: In this database the chem name or chemical name refers to the chemical 
composition of the drug. 
SMILES (Simplified Molecular Input Entry System):  
        
“The simplified molecular-input line-entry system (SMILES) is a specification in 
form of a line notation for describing the structure of chemical molecules using 
short ASCII strings. SMILES strings can be imported by most molecule editors for 
conversion back into two-dimensional drawings or three-dimensional models of the 
molecules.”(Source: Wikipedia) 
 
Category: The category the drug belongs to and is taken from JHCCL database. E.g., 
analgesic, anesthetic, appetite stimulants, antacids, antibacterial/antibiotic, antiamoebic 
FDA_adults (Food and Drug Adminstration_adults): If the drug is FDA approved for 
adults this column will have a value = + and if it is not FDA approved this column will 
have a value = -. 
FDA_PEDS (Food and Drug Administration PEDS): If the drug is FDA approved for 
children this column will have a value = + and age range suited for children (e.g. +>3m 
where m stands for months) and if it is not FDA approved for children then the value = -. 
Indication: This mentions the uses of each drug e.g. hypertension. i.e. the drug can be used 
for patients with hypertension. 
indication_preclinical: This mentions the use of the drug before clinical approval. This 
column stores the new uses identified for the drug and it is yet to be approved. 
indication_pateint 
MOA (Mechanism of Action):  
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”In pharmacology, the term mechanism of action (MOA) refers to the specific 
biochemical interaction through which a drug substance produces its 
pharmacological effect. A mechanism of action usually includes mention of the 
specific molecular targets to which the drug binds, such as an enzyme or 
receptor.”(Source: Wikipedia) 
 
Company: The name of the company that produces the drug.  
link_to_website: Link to other chemical/medical databases. Currently this column stores 
link to the ChemSpider website.  “(ChemSpider is a free chemical structure database 
providing fast text and structure search access to over 32 million structures from hundreds 
of data sources. (Source: ChemSpider website)).” 
 
This was the initial draft version of the database, with further discussions with the 
Oncology Department we came up with a design to create three tables. The main reason 
for creating three tables is to store multiple values for brand name and uses for each drug. 
The main table consists of the fields which contain one value for each drug and are directly 
related to the CPC_ID so the main table stores the CPC_ID, JHCCL_ID, chem_name, 
SMILES and link_to_website. The second table is to store the brand names of the drugs 
and this will store Brand_ID (unique/ primary key for this table), CPC_ID, generic_name, 
brand_name and company. The last table is to store the various uses of the drugs, there 
were a few changes made to the columns in this table from the initial table design. The 
FDA_Adults and FDA_PEDS column was combined into one in order to reduce data 
redundancy since both fields are used for identifying if the drug is FDA approved.   The 
three indication fields i.e. indication, indication_preclinical and indication_patient were 
also combined into one indication field and a status field was added in order to identify the 
status of the indication.  
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        This table stores the Indication_ID (Unique/primary ID), CPC_ID, Indication, Status, 
FDA_Status, Disease (the category column name was changed into this) and MOA.  
The CPC_ID is used as a foreign key in the brand and indication tables and is used to 
connect these tables to the main master table.  
The detailed description of the three tables are below: 
Main Table:  
Field Type Null Key Default 
CPC_ID char(7) NO PRI NULL 
JHCCL_ID int(11) YES  NULL 
chem_name varchar(100) YES  NULL 
SMILES varchar(100) YES  NULL 
link_to_website varchar(30) YES  NULL 
 
Definitions of all the table elements: 
CPC_ID:  Childrens Pharmacy Collaborative ID. This is a unique ID to identify each drug. 
The CPC_ID was assigned by the Oncology team and currently it ranges from CPC_0001 
to CPC_1242. It can hold up to CPC_9999 values. 
JHCCL_ID: This is ID taken from the John Hopkins Database. It is used mainly as a 
reference to the master John Hopkins Database. This is an integer and has values from 0 to 
999999. In our database there is no specific range since it is taken from the JHCCL 
Database. 
chem_name: In this database the chem name or chemical name refers to the chemical 
composition of the drug. 
SMILES (Simplified Molecular Input Entry System):  
“The simplified molecular-input line-entry system (SMILES) is a specification in 
form of a line notation for describing the structure of chemical molecules using 
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short ASCII strings. SMILES strings can be imported by most molecule editors for 
conversion back into two-dimensional drawings or three-dimensional models of the 
molecules.”(Source: Wikipedia) 
 
link_to_website: Link to other chemical/medical databases. Currently this column stores 
link to the ChemSpider website. “(ChemSpider is a free chemical structure database 
providing fast text and structure search access to over 32 million structures from hundreds 
of data sources. (Source: ChemSpider website)).”  
Brand Name: 
Field Type Null Key Default 
Brand_ID char(7) NO PRI NULL 
CPC_ID char(7) NO FOREIGN NULL 
generic_name varchar(30) YES  NULL 
brand_name varchar(30) YES  NULL 
company varchar(40) YES  NULL 
 
Definitions of all the table elements: 
Brand_ID: This is the unique ID for this table to uniquely identify each row of the 
database. 
CPC_ID:  Childrens Pharmacy Collaborative ID. This is a unique ID to identify each drug. 
The CPC_ID was assigned by the Oncology team and currently it ranges from CPC_0001 
to CPC_1242. It can hold up to CPC_9999 values. 
generic_name: This is the chemical name of the drug and it will indicate the main 
ingredient of the drug. The generic ingredient can have many different brand names. 
brand_name: This is the commonly used name of the drug and it is given by the company 
producing the drug. For example: Tylenol is the brand name of the drug and acetaminophen 
is the generic name.  
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Company: The name of the company that produces the drug.  
Indication Name: 
FIELD TYPE NULL KEY DEFAULT 
Indication_ID char(7) NO PRI NULL 
CPC_ID char(7) NO FOREIGN NULL 
Indication varchar(100) YES NULL  
Status varchar(20) YES   
FDA_Status varchar(5) YES NULL  
Disease     
MOA varchar(100) YES NULL  
 
Definitions of all the table elements: 
Indication_ID: This is the unique ID for this table to uniquely identify each row of the 
database. 
CPC_ID:  Childrens Pharmacy Collaborative ID. This is a unique ID to identify each drug. 
The CPC_ID was assigned by the Oncology team and currently it ranges from CPC_0001 
to CPC_1242. It can hold up to CPC_9999 values. 
Disease: The category the drug belongs to and is taken from JHCCL database. E.g., 
analgesic, anesthetic, appetite stimulants, antacids, antibacterial/antibiotic, antiamoebic 
FDA_Status (Food and Drug Adminstration_adults): Specifies if the drug is FDA 
approved or not. This field will have the following values:  
 PEDS – If the drug is approved only for children 
 Adult – If the drug is approved only for adults.  
 Both – If the drug is approved for both adults and children.  
 None – If the drug is not FDA approved.  
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Indication: This mentions the uses of each drug e.g. hypertension. i.e. the drug can be used 
for patients with hypertension. 
Status: This mentions the status of the indication of the drug. The status field has the below 
values: 
 Preclinical – If the indication was not approved for clinical use. 
 Clinical – If the indication is approved for clinical use.  
MOA (Mechanism of Action):  
 
”In pharmacology, the term mechanism of action (MOA) refers to the specific 
biochemical interaction through which a drug substance produces its 
pharmacological effect. A mechanism of action usually includes mention of the 
specific molecular targets to which the drug binds, such as an enzyme or 
receptor.”(Source: Wikipedia) 
 
Company: The name of the company that produces the drug.  
link_to_website: Link to other chemical/medical databases. Currently this column stores 
link to the ChemSpider website. “(ChemSpider is a free chemical structure database 
providing fast text and structure search access to over 32 million structures from hundreds 
of data sources. (Source: ChemSpider website)).” 
4.6. Formatting the data and loading data into database 
 
The data provided was manually formatted and loaded into the table. 
This data was quite straight forward, for the initial single database design there was no data 
formatting and the data was directly loaded into the table from the excel sheet. The excel 
sheet was converted into a csv file and this file was then loaded into the database. The next 
step was to verify this table by using the SQL queries which were formed based on the user 
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queries. Based on these results the database design was changed and a new design was 
created with three tables.   
I created three csv files from the main excel sheet to load these tables.  
The main table has the columns: CPC_ID, JHCCL_ID, SMILES, chem_name and 
link_to_website. These columns were directly taken from the main excel spreadsheet and 
converted into a csv file. The brand table has the following columns: Brand_ID (primary 
key and is auto generated), CPC_ID (foreign key that connects this table to the main table), 
generic_name, brand_name and company. The last three columns are associated with the 
Brand_ID and stores the multiple brand name for each drug. These columns were manually 
formatted and entered into an excel spreadsheet from the original excel spreadsheet. This 
spreadsheet was converted into a csv file and loaded into the Brand Name table.  
The indications table has the columns: Indication_ID (primary key and is auto generated), 
CPC_ID (foreign key that connects this table to the main table), MOA was also directly 
loaded from the main excel spreadsheet, the rest of the columns and details about 
formatting those columns are listed below: 
 Indication and Status: This column was created by merging the indication, 
indication_preclinical and indication_patient columns. The indication and 
indication_patient columns are redundant columns so they were combined into one 
for each drug and the status was set to clinical for these columns. All the values in 
indication and indication_patient were taken for each drug and converted into one 
indication column for each drug with a unique indication_id, if there were more 
than one indication for a drug that was entered as a new row with a unique 
indication_id and the CPC_ID remained the same. The value in the 
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indication_preclinical column was moved into the indication column in this table 
and the status was set to preclinical. So a single drug can have multiple rows for 
multiple indications and status. 
 FDA_Status: This column was created by merging the FDA_Adults and 
FDA_PEDS column. I used excel functions to set a flag to mark this FDA status in 
a new column and converted that column into the appropriate FDA_Status values 
as mentioned in the previous section.  
 Disease: This is the same as the category column so this required no formatting.  
4.7. Search and Retrieval 
 
Consistent and accurate data will ensure effective search and retrieval of data. 
Search and retrieval of data in this database will be carried out using the metadata from the 
table columns. Users will use the metadata associated with each drug in order to query the 
database and retrieve relevant and necessary information. A user interface will eventually 
be developed to provide effective search and retrieval. This interface will use the metadata 
fields as search fields. 
5. Results 
 
  From the analysis of the literature the main techniques identified are the 
usage of relational database and manual curation for effective storage, search and retrieval 
of information in medical databases. The most common technique for information storage 
and curation in medical databases is manual curation. This is because experts in their 
respective fields perform manual curation so they have better understanding and expertise 
as well as control over medical data. Since medical data is very crucial and even small 
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errors in the data accuracy will lead to the dissatisfaction and also cause bad side effects to 
common people or consumers who have no understanding of medical data. Especially this 
database is for children and inaccurate data or information might lead to irreparable side 
effects if the wrong drug is used. It is ideal to ensure that experts in the field manually 
curate and annotate this data and they have control over every drug that goes into this 
database. Also using a relational database will ensure data consistency and flexible 
querying of the database which in turn will improve search and retrieval of information 
that will benefit the end users of this system.  
 By the end of this project all the objectives mentioned before were met and the 
database was designed and loaded effectively and successfully. The results are discussed 
in detail below: 
Database Design: 
 The database was designed as per the requirements of Division of Pediatric 
Hematology Oncology in UNC, Chapel Hill based on the user’s needs/queries and the excel 
spreadsheet of pediatric drugs data provided them. The database design was performed in 
iterative improvements based on the feedback from the Oncology team. Initially a single 
database was created and it was reviewed with the team and based on their feedback a 
database system consisting of three databases were created as the first main database which 
stores the CPC_ID, JHCCL_ID, chem_name, SMILES, link_to_websites, the second brand 
tables which stores Brand_ID, CPC_ID, generic_name, brand_name and company and 
finally the indication table which stores Indication_ID, CPC_ID, indication, status, 
FDA_status, Disease and MOA. The final three databases were approved by my advisor 
and the Oncology team in UNC, Chapel Hill. 
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Loading of data: 
 The data from excel spreadsheet was then formatted as per the database schema and 
loaded into the three databases. This was reviewed with my advisor and the Oncology team 
in UNC, Chapel Hill and approved by them. 
6. Evaluation of the Database 
 
The database was evaluated by writing SQL queries for the user queries identified. 
These SQL queries were run against the table and the results were returned in less than 
0.01 seconds. The results were returned faster since that database is small in size. The 
results to the user query from the three table’s i.e. main table, brand table and indications 
table are documented below along with the refined queries.Scientists: 
1. What are the original/repurposed uses for specific drugs? 
Search against both generic and brand names 
SQL Query: 
SELECT a.generic_name, b.indication, b.status  
    FROM generic_name a, indications b  
  WHERE a.CPC_ID = b.CPC_ID  
         AND a.generic_name = 'Crizotinib'; 
  
generic_name   indication                                                      status    
 Crizotinib     Neuroblastoma anaplastic LCL myofibroblastic tumors (P) NSCLC   Clinical  
 
Search based on brand name of drug: 
SQL Query 
SELECT a.generic_name, b.indication, b.status  
   FROM generic_name a, indications b  
WHERE a.CPC_ID = b.CPC_ID   
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       AND a.generic_name LIKE 'Da%’; 
 
generic_name        indication          
 
status    
 Amphetamine         ADHD narcolepsy(P)   Clinical  
 Dextroamphetamine                         
 
Search based on generic name of drug where the whole name is not specified. (The 
below query shows generic name starting with da) 
 
SQL Query: 
SELECT a.generic_name, b.indication, b.status  
   FROM generic_name a, indications b  
 WHERE a.CPC_ID = b.CPC_ID  
       AND a.generic_name like 'Da%'; 
 
generic_name       indication                             
 
status    
 Dacarbazine        Hodgkin (P)                             Clinical  
 Daclizumab                                                           
 Dactinomycin       Wilms EWS (P)                           Clinical  
 DalteparinSodium                                                     
 Danazol            ITP SAA (P) endometriosis               Clinical  
 Dantrolene         malignant hyperthermia spasticity (P)   Clinical  
 Dapiprazole                                                          
 Dapsone            leprosy dermatitis herpetiformis (P)    Clinical  
 Daptomycin                                                           
 DarbepoetinAlfa                                                      
 Darunavir          HIV (P)                                 Clinical  
 Dasatinib          CML (P)                                 Clinical  
 Daunorubicin       ALL AML (P)                             Clinical  
 
2. Do other drugs in category/with original indications/with similar chemical 
structure/similar MOA have potential for similar repurposing? Removed similar 
repurposing from the query as per discussions and changed the above query as: Do 
other drugs in disease/with original indications? Category changed to disease as per 
our discussion. 
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a. What other drugs have the same indications? 
SQL Query:  
 
SELECT A.generic_name, A.brand_name, B.disease 
   FROM generic_name A, indications B  
WHERE A.CPC_ID = B.CPC_ID 
      AND B.disease = (SELECT C.disease 
                   FROM indications C, generic_name D 
                         WHERE C.CPC_ID = D.CPC_ID 
                                 AND D.generic_name = 'Rufinamide'); 
 
generic_name       brand_name            disease         
 Atracurium                              Anticonvulsant  
 Beclamide          Chloracon            Anticonvulsant  
 Carbamazepine      tegretol             Anticonvulsant  
 Cetrimide                               Anticonvulsant  
 Clonazepam         klonopin             Anticonvulsant  
 DivalproexSodium   depakote             Anticonvulsant  
 Ethosuximide       zarontin             Anticonvulsant  
 Felbamate                               Anticonvulsant  
 Flurazepam                              Anticonvulsant  
 Fosphenytoin       cerebyx              Anticonvulsant  
 Gabapentin                              Anticonvulsant  
 Gabapentin                              Anticonvulsant  
 GlutamicAcid                            Anticonvulsant  
 Lamotrigine        lamictal             Anticonvulsant  
 Levetiracetam      keppra               Anticonvulsant  
 Mephenytoin                             Anticonvulsant  
 Mephobarbital                           Anticonvulsant  
 Methsuximide       celontin             Anticonvulsant  
 Nitrazepam                              Anticonvulsant  
 Oxcarbazepine      trileptaloxtellarXR  Anticonvulsant  
Paramethadione                          Anticonvulsant  
 Perampanel         Fycompa              Anticonvulsant  
 Phenacemide                             Anticonvulsant  
 Phenobarbital      luminal              Anticonvulsant  
 Phensuximide                            Anticonvulsant  
 Phenytoin          dilantin             Anticonvulsant  
 Pregabalin         lyrica               Anticonvulsant  
 Primidone                               Anticonvulsant  
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 Rufinamide         banzel               Anticonvulsant  
 Stiripentol                             Anticonvulsant  
 Tiagabine          gabatril             Anticonvulsant  
 Topiramate         topamax              Anticonvulsant  
 ValproicAcid                            Anticonvulsant  
 Vigabatrin                              Anticonvulsant  
 Zonisamide         zonegram             Anticonvulsant  
  
3. What structures similar to this one exist outside the database (requires download of 
structure file)? 
This query is more specific to the user interface and is outside the scope of this project. 
 
Clinicians: 
1. What are the original/repurposed uses for specific drugs? 
Refer to scientist’s query 1. 
2. Which drugs are FDA approved in pediatrics and for what indications?  
SQL Query: 
SELECT a.generic_name, b.indication, b.status  
   FROM generic_name a, indications b  
 WHERE a.CPC_ID = b.CPC_ID  
       AND b.FDA_status IN ("Peds" or "Both"); 
 
generic_name indication status 
Valsartan                                                                                                        
Vancomycin                      CNS tumors (P) thyroid ca                                          Preclinical  
Vandetanib                                                                                                       
Varicella-ZosterImmuneGlobulin                                                                                   
Vasopressin                                                                                                      
VecuroniumBromide               
brain stem gangioglioma 
melanoma(P)                             Preclinical  
 vemurafenib                                                                                                      
 Venlafaxine                                                                                                      
 Verapamil                                                                                                        
 Vigabatrin                                                                                                       
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 Vinblastine                                                                                                      
 Vincristine                                                                                                      
 Vinorelbine                      basal cell                                                        Preclinical  
 Vismodegib                                                                                                       
 VitaminA                                                                                                         
 VitaminBComplex                                                                                                  
 VitaminB12                                                                                                       
 VitaminE                                                                                                         
 Voriconazole                                                                                                     
 Warfarin                                                                                                         
 YellowFeverVaccine                                                                                               
 Zafirlukast                      HIV                                                               Preclinical  
 Zalcitabinedideoxycytidine                                                                                       
 Zanamivir                                                                                                        
 Zidovudine                                                                                                       
 Zileuton                                                                                                         
 ZincChloride                                                                                                     
 Ziprasidone                                                                                                      
 Zolpidem                                                                                                         
 Zonisamide                                                                                                       
 
Consumers: 
1. What drugs are FDA approved in children? 
SQL Query: 
SELECT a.generic_name, a.brand_name  
   FROM generic_name a, indications b  
 WHERE a.CPC_ID = b.CPC_ID  
       AND b.FDA_status IN ("Peds" or "Both");  
  
generic_name brand_name 
 Spinosad                         natroba                         
 Spiramycin                                                       
 Spironolactone                   aldactone                       
 St.John'sWort                                                    
 Stanozolol                                                       
 Stavudine                        zerit                           
 Stiripentol                                                      
 Streptokinase                                                    
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 StreptomycinSulfate                                              
 suberanilo-hydroxamicacidSAHA   
 
vorinostatzolinza               
 Succimer                         chemet                          
 Succinylcholine                  antilirium                      
 Sucralfate                       carafate                        
 Sucrose                                                          
 Sufentanil                                                       
 Sulfacetamide                                                    
 Sulfadiazine                                                     
 Sulfadoxine                                                      
 Sulfamethizole                                                   
 Sulfamethoxazole                                                 
 Sulfasalazine                    azulfidine                      
 Sulfinpyrazone                   anturane                        
 Sulfisoxazole                    gantrisin                       
 Sulfur                                                           
 Sulindac                         clinoril                        
 Sumatriptan                      alsumaimitrex                   
 Sunitinib                                                        
 Suramin                                                          
 Tacrolimus                       protopic                        
 Tamoxifen                                                        
 Tazarotene                                                       
 TechnetiumTc99mApcitide          acutect                         
 Temsirolimus                     Torisel                         
 Temozolomide                     Temodar                         
 Teniposide                                                       
 Tenofovir                        Viread                          
 TenofovirDisoproxilFumarate      Viread                          
 Terazosin                                                        
 Terbinafine                                                      
 Terbutaline                                                      
 Testosterone                     androderm                       
 TetanusImmuneGlobulin                                            
 TetanusToxoid                                                    
 Tetracaine                                                       
 Tetracycline                     actiste                         
 Thalidomide                                                      
 Theophylline                     accurbron                       
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 Thiamine                         thiomalate                      
 Thioguanine                                                      
 Thiopental                       pentothal                       
 Thioridazine                                                     
 Thiosulfate                                                      
 Thiotepa                                                         
 Thiothixene                                                      
 Thrombin                                                         
 Thyroxine                                                        
 Tiagabine                        gabatril                        
 Ticarcillin                      ticar                           
 Timolol                                                          
 Tipranavir                                                       
 Tobramycin                       aktob                           
 Tocilizumab                      actemra                         
 Tolnaftate                       aftate                          
 Tolterodine                      detrol                          
 Topiramate                       topamax                         
 Topotecan                        hycamptin                       
 Torsemide                                                        
 Tramadol                                                         
 TranexamicAcid                   lysteda                         
 Trazodone                                                        
 Tretinoin                        AvitaATRA                       
 Triamcinolone                    aristocort                      
 Triamterene                      dyrenium                        
 Triazolam                                                        
 Trifluoperazine                                                  
 Trifluridine                                                     
 Trihexyphenidyl                  artane                          
 Trimethobenzamide                tigan                           
 Trimethoprim                                                     
 Triprolidine                     actidil                         
 Tromethamine                                                     
 Tropicamide                                                      
 Tymazoline                                                       
 UndecylenicAcid                                                  
 Urokinase                        abbokinase                      
 Ursodiol                         actigall                        
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 Valacyclovir                     valtrex                         
 Valganciclovir                   valcyte                         
 ValproicAcid                                                     
 Valsartan                        diovan                          
 Vancomycin                                                       
 Vandetanib                                                       
 Varicella-ZosterImmuneGlobulin   vzig                            
 Vasopressin                      pitressin                       
 VecuroniumBromide                                                
 vemurafenib                      zelboraf                        
 Venlafaxine                                                      
 Verapamil                        verelan                         
 Vigabatrin                                                       
 Vinblastine                                                      
 Vincristine                                                      
 Vinorelbine                      navelbine                       
 Vismodegib                                                       
 VitaminA                                                         
 VitaminBComplex                                                  
 VitaminB12                                                       
 VitaminE                                                         
 Voriconazole                     vfend                           
 Warfarin                         cofarin                         
 YellowFeverVaccine                                               
 Zafirlukast                      accolate                        
 Zalcitabinedideoxycytidine       hivid                           
 Zanamivir                                                        
 Zidovudine                       AZT                             
 Zileuton                                                         
 ZincChloride                                                     
 Ziprasidone                                                      
 Zolpidem                         ambien                          
 Zonisamide                       zonegram                        
 
2. Have consumers used a particular drug for other than approved or conventional 
indications? What was their experience (and evidence for comments)? 
This query is specific to the user interface and it outside the scope of this project.  
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3. What is the MOA and what drug have similar MOA for comparison? 
SQL Query:   
SELECT a.generic_name, a.brand_name, b.MOA 
   FROM generic_name a, indications b 
 WHERE a.CPC_ID = b.CPC_ID 
       AND b.MOA = (SELECT c.MOA 
                                   FROM indications c, generic_name d 
                                 WHERE c.CPC_ID = d.CPC_ID 
 AND d.generic_name = 'Donepezil'); 
 
generic_name  
 
brand_name   MOA                            
 Donepezil      Aricept      acetylcholinesteraseinhibitor  
 
 
Pharmaceuticals: 
1. What are the original/repurposed uses for specific drugs? 
Refer to scientists’ query 1. 
2. Do other drugs in category/with original indications/with similar chemical 
structure/similar MOA have potential for similar repurposing? Removed similar 
repurposing from the query as per discussions and changed the above query as: Do 
other drugs in disease/with original indications? Category changed to disease as per 
our discussion. 
Refer to scientists’ query 2. 
3. What structures similar to this one exist outside the database (requires download of 
structure file)? 
This query is specific to the user interface and it outside the scope of this project. 
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7. Limitations 
 
  This is a new database and information is retrieved manually from the 
JHCCL database and there is no way of identifying if the data is correct. Also manual 
annotation and curation may lead to small errors in the information. Results are very 
context dependent on data, clinical environment and usage, etc. 
8. Conclusion and Future Work 
  
Medical informatics is gaining momentum and there are multiple medical databases 
available today. This database is mainly for pediatric drugs since there is no database that 
is specific for children currently. This database will start with ~1200 drugs and metadata 
corresponding to each drug will also be added. Consumers, physicians, pharmaceutical 
companies and scientists will use this database. Through this project existing literature was 
analyzed to identify the structure and methods of data curation in order to provide efficient 
and effective search and retrieval for this children’s drug database. This paper discusses 
the analysis of the user group and user queries, analysis of existing medical databases and 
design and creation of a database system to support the children’s drug database initiative 
and the results for user queries from this database system have been documented. One of 
the major reasons for this initiative is to provide users drug repurposing for pediatric drugs. 
Currently the JHCCL database holds ~ 10000 drugs and through this initiative the Division 
of Pediatric Hematology Oncology in UNC, Chapel Hill have identified ~1200 drugs that 
can be classified for pediatric usage.  
This repository is not complete yet and it requires curation since many of the drugs 
are not yet classified with disease and also the indications have not been identified for 
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them. The next major step would be to use this database and verify the information 
provided for the drugs. Since this data was created manually a curation team needs to be 
created in order to spend more time and effort to produce accurate data and complete the 
missing information in this repository. Once this has been achieved a user interface or 
website will be created for the end users.   
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